Find an Expert
Search
Menu
Help
Report an issue
Using patient derived cells to define an electrical signature of sporadic ALS and to develop a high throughput drug screening technology and novel therapy
| Funding period: 2021 - 2022
Completed
University of Melbourne Researchers
Saman Halgamuge
Mechanical Engineering